# Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses

Elias A Said, Petronela Ancuta, Jean-Pierre Routy, Jean Pierre Vartanian, Ali A Al-Jabri

► To cite this version:

Elias A Said, Petronela Ancuta, Jean-Pierre Routy, Jean Pierre Vartanian, Ali A Al-Jabri. Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses. Frontiers in Immunology, 2023, 14, pp.1137399. 10.3389/fimmu.2023.1137399. pasteur-04328508

HAL Id: pasteur-04328508

https://pasteur.hal.science/pasteur-04328508

Submitted on 7 Dec 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Check for updates

## OPEN ACCESS

EDITED AND REVIEWED BY
Pei-Hui Wang,
Shandong University, China

*CORRESPONDENCE

Elias A. Said

<figure><img src="image_3.png" /></figure>

elias.said@gmail.com

## SPECIALTY SECTION

This article was submitted to
Viral Immunology,
a section of the journal
Frontiers in Immunology

RECEIVED 04 January 2023

ACCEPTED 16 January 2023

PUBLISHED 07 February 2023

## CITATION

Said EA, Ancuta P, Routy J-P, Vartanian J-P and Al-Jabri AA (2023) Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses.
*Front. Immunol.* 14:1137399.
doi: 10.3389/fimmu.2023.1137399

## COPYRIGHT

© 2023 Said, Ancuta, Routy, Vartanian and Al-Jabri. This is an open-access article distributed under the terms of the *Creative Commons Attribution License (CC BY)*. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

# Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses

Elias A. Said¹*, Petronela Ancuta²,³, Jean-Pierre Routy⁴,⁵, Jean-Pierre Vartanian⁶ and Ali A. Al-Jabri¹

¹Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Gaboos University, Muscat, Oman. ²Département de microbiologie, infectiologie et immunologie, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada. ³Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. ⁴Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada. ⁵Division of Hematology, McGill University Health Centre, Montreal, QC, Canada. ⁶Virus and Cellular Stress Unit, Department of Virology, Institut Pasteur, Université de Paris Cité, Paris, France

## KEYWORDS

adaptive immunity, enveloped viruses, HIV, HBV, F-MULV, COVID-19, PRRSV, atherosclerosis

## Editorial on the Research Topic

### Modulation of the adaptive immune responses and the chronicity of infections with enveloped viruses

Virus structures began to be understood in the 1930s with Stanley, Bernal, and Fankuchen's work on the tobacco mosaic virus. Following the initial description, the lipid bilayer membrane on the outer part of the virus differentiated enveloped from non-enveloped viruses. For non-enveloped viruses that do not possess that extra lipid membrane, cell lysis is the most common exit mode from the host cell. Conversely, enveloped viruses contain an outer membrane that surrounds the capsid, and during virus assembly and exit from host cells, these viruses use the host cell membrane itself to assemble their membrane, known as an envelope (1). This process avoids cell lysis and helps enveloped viruses escape the host immune system. Furthermore, the persistence of these viruses, even at low levels, inhibits the development of antigen-independent memory CD8 T cells, resulting in the exhaustion of the immune response with persistent inflammation (2). Enveloped viruses can potentially cause chronic infections that represent major risks to human health. A significant number of enveloped viruses that can cause chronic infections are pandemic, affect hundreds of millions of people, and some of them cause the deaths of millions of humans. This includes some viruses associated with immune deficiencies and cancer, such as Epstein-Barr virus (EBV), hepatitis C and B viruses (HCV and HBV), human cytomegalovirus (HCMV), and human immunodeficiency virus (HIV). The chronic infections caused by these viruses and the lack of efficient vaccines against many of them are important public health challenges. Therefore, to develop efficient treatments and vaccines against these viruses, it is crucial to understand the mechanisms and factors that modulate the adaptive immune responses in chronic infections with enveloped viruses. Additionally, this will help elucidate the criteria, parameters, and correlates that should be considered for the design of new vaccines. This Research Topic contains one review and five research articles that address the mechanism and factors that
modulate the adaptive immune responses in chronic infections with enveloped viruses and the consequences on the dynamic of these infections.

HIV infection is a major threat to global health. Potent B cell responses are a key factor in controlling this infection. In their article, Noto et al. investigated the impact of HIV infection on T follicular helper (Tfh) cell subsets and the resulting effect on B cell responses. They reported a decrease in T helper 2 (Th2)-like Tfh cells, which are CXCR3⁻ and produce single interleukin 4 (IL-4) and dual IL-21/IL-4 during HIV replication. The authors also indicated that the percentage of these Th2-like Tfh cells is associated with the total number and cycling of HIV-specific B cells, and that the percentage of Th1-like Tfh cells, which are CXCR3⁺ and produce single interferon-γ (IFN-γ) and dual IL-21/IFN-γ, is associated with HIV-specific B cells that have both CXCR3 and T-bet. IFN-γ induced the expression of CXCR3 and T-bet in B cells, and IL-4 and IL-21 enhanced the maturation of HIV-specific B cells. Additionally, Noto et al. demonstrated that harboring of CXCR3 is associated with a low rate of somatic hypermutations in B cells. Together, this demonstrates that the Th2/Th1-like Tfh imbalance in viremic HIV patients has an impact on B cell responses.

Another interesting phenomena was reported by Podschwadt et al., who demonstrated that the envelope (Env) of the retrovirus Friend murine leukemia virus (F-MuLV) induces IL-10-producing CD4 T cells upon immunization. These CD4 T cells were associated with the suppression of anti-Env CD8 T cell responses. F-MuLV could also reduce the control of tumors by immune cells. This capacity of the Env protein to affect CD8 T cell responses was also observed with gamma retroviruses other than F-MuLV.

Understanding how adaptive immune responses can control the long-term effects of the infection with enveloped viruses is crucial for developing strategies aimed at limiting these infections. Kundura et al. suggested the presence of an association between decreased levels of perforin-expressing CD8 T cells and long coronavirus-induced disease (long COVID) attributed to the persistence of symptoms upon infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This sheds light on the importance of boosting antiviral CD8 T cell responses in the early phases of infection with enveloped viruses.

Moreover, strategies aimed at eradicating established chronic infections with enveloped viruses are urgently required. Debelec-Butuner et al. demonstrated the capacity of a combination of bispecific antibodies directed against CD3 or CD28 and the hepatitis B virus (HBV) envelop protein and trispecific antibodies directed against these molecules to engage T cells to eradicate the covalently closed circular DNA of HBV, which is associated with viral chronicity. They compared the capacity of these antibodies to induce cytolytic and cytokine-mediated responses to that of S-CAR T cells. The antibodies induced higher levels of cytokines, and the combined bispecific antibodies induced the highest level of antiviral cytokine production. The study demonstrated the capacity of multispecific antibodies to control viral infections.

The development of treatments that can improve the control of chronic infections with enveloped viruses is a major aspect in managing the spread of these infections. Ruansit et al. demonstrated that molecules in Hottuynia cordata (HC), a Chinese herbal remedy, can inhibit infection with porcine reproductive and respiratory syndrome virus (PRRSV). Additionally, HC can induce cytokine production in monocyte-derived macrophages. Treatment with HC resulted in a stronger decrease in the highly pathogenic (HP)-ORRSV-2 load in pigs vaccinated with PRRSV-1 modified-live virus (MLV). This was associated with an increase in IFN regulatory factor 3 (IRF-3). This highlights the potential benefit of combining treatment and vaccination to improve the control of viral infections.

Moreover, in this Research Topic, Talepoor et al. reviewed the literature about the capacity of some chronic viral infections to induce mechanisms that are associated with aging and atherosclerosis, including sustained cytokine signaling and DNA damage. They highlighted the ability of CMV, EBV, and HBV to upregulate senescence-associated molecules, including the tumor-suppressor proteins p16, p21, and p53, and induce replicative senescence and inflammaging. Talepoor et al. also commented on the induction of DNA damage, senescence-associated secretory phenotype (SASP) telomere shortening, and epigenetic modifications of DNA by hepatitis C virus (HCV) and HIV.

Altogether, the authors underlined the importance of several mechanisms involving the adaptive immune system that can control chronic infections with enveloped viruses. This represents a crucial weapon in the arsenal required for the potential prevention and eradication of these viral infections.

## Author contributions

ES wrote the manuscript, AA-J, PA, J-PR and J-PV modified and added parts to the manuscript. All authors contributed to the article and approved the submitted version.

## Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

## Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References

1. Song JM, Seong BL. Viral membranes: an emerging antiviral target for enveloped viruses? *Expert Rev Anti Infect Ther* (2010) 8:635-8. doi: 10.1586/eri.10.51

2. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. *J Virol* (2004) 78:5535-45. doi: 10.1128/JVI.78.11.5535-5545.2004